bf/NASDAQ:FBIO_icon.jpeg

NASDAQ:FBIO

Fortress Biotech, Inc.

  • Stock

USD

Last Close

1.39

25/09 14:38

Market Cap

35.72M

Beta: 1.99

Volume Today

70.01K

Avg: 589.37K

PE Ratio

−0.12

PFCF: −0.22

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
863K
-
16.48M
1,809.62%
187.58M
1,038.25%
26.88M
85.67%
36.63M
36.26%
45.60M
24.49%
68.79M
50.86%
75.74M
10.11%
84.51M
11.58%
cost of revenue
11.35M
-
161.20M
1,320.41%
6.13M
96.20%
10.53M
71.95%
14.59M
38.57%
32.08M
119.84%
30.77M
4.08%
28.89M
6.13%
gross profit
863K
-
5.13M
494.55%
26.38M
414.17%
20.76M
21.32%
26.10M
25.73%
31.00M
18.81%
36.71M
18.39%
44.97M
22.51%
55.62M
23.69%
selling and marketing expenses
10.41M
-
155.19M
1,390.18%
general and administrative expenses
10.10M
-
10.41M
3.12%
21.58M
107.28%
35.16M
62.91%
73.02M
107.65%
53.37M
26.90%
55.59M
4.16%
selling general and administrative expenses
10.10M
-
10.41M
3.12%
21.58M
107.28%
35.16M
62.91%
73.02M
107.65%
53.37M
26.90%
55.59M
4.16%
61.17M
10.03%
86.84M
41.98%
113.66M
30.88%
88.79M
21.87%
research and development expenses
25.68M
-
10.24M
60.13%
29.81M
191.14%
35.13M
17.86%
52.49M
49.39%
87.38M
66.49%
81.33M
6.93%
64.11M
21.17%
128.87M
101.01%
134.88M
4.66%
106.07M
21.36%
other expenses
11.41M
-
-9.87M
186.51%
-234K
97.63%
68K
129.06%
6.09M
8,855.88%
2.83M
53.46%
25.16M
787.97%
-1.30M
105.18%
-3.40M
160.97%
cost and expenses
35.78M
-
20.65M
42.28%
51.39M
148.86%
82.19M
59.92%
288.79M
251.37%
146.88M
49.14%
147.45M
0.39%
139.87M
5.14%
247.79M
77.16%
278.00M
12.19%
223.75M
19.51%
operating expenses
35.78M
-
20.65M
42.28%
51.39M
148.86%
70.84M
37.84%
127.59M
80.11%
140.75M
10.32%
136.92M
2.73%
125.28M
8.50%
215.71M
72.19%
247.23M
14.61%
194.87M
21.18%
interest expense
1.90M
-
1.34M
29.69%
1.48M
10.91%
3.69M
148.65%
5.86M
58.81%
10.34M
76.45%
11.85M
14.59%
9.70M
18.10%
15.31M
57.75%
13.64M
10.88%
11.91M
12.66%
ebitda
-35.24M
-
-19.99M
43.27%
-50.29M
151.56%
-64.28M
27.84%
-98.53M
53.28%
-116.77M
18.50%
-103.61M
11.27%
-93.05M
10.19%
-178.35M
91.68%
-200.86M
12.62%
-131.17M
34.70%
operating income
-35.78M
-
-20.65M
42.28%
-50.53M
144.68%
-65.71M
30.04%
-101.21M
54.02%
-120.00M
18.56%
-110.82M
7.65%
-94.27M
14.93%
-179.00M
89.88%
-202.26M
12.99%
-139.24M
31.16%
depreciation and amortization
17K
-
23K
35.29%
26K
13.04%
1.13M
4,234.62%
2.09M
85.36%
2.06M
1.44%
7.21M
250.32%
1.22M
83.07%
649K
46.85%
1.40M
115.41%
8.07M
477.61%
total other income expenses net
-1.38M
-
942K
168.36%
-2.11M
324.31%
-2.19M
3.55%
7.93M
462.25%
-1.57M
119.77%
9.16M
684.49%
-8.58M
193.67%
14.65M
270.74%
-11.20M
176.49%
-14.39M
28.45%
income before tax
-37.16M
-
-20.39M
45.14%
-53.88M
164.31%
-71.29M
32.31%
-98.32M
37.92%
-130.80M
33.03%
-101.66M
22.28%
-102.85M
1.17%
-164.35M
59.80%
-213.46M
29.88%
-153.63M
28.03%
income tax expense
525K
-
1.31M
150.48%
-4.00M
403.95%
-12.51M
212.86%
1.51M
112.10%
-463K
130.60%
-49.85M
10,666.95%
136K
100.27%
473K
247.79%
449K
5.07%
521K
16.04%
net income
-37.16M
-
-20.39M
45.14%
-48.43M
137.56%
-55.09M
13.77%
-66.88M
21.38%
-84.15M
25.83%
-51.81M
38.43%
-102.98M
98.78%
-164.83M
60.05%
-213.91M
29.78%
-60.64M
71.65%
weighted average shs out
2.03M
-
2.42M
19.37%
2.61M
7.77%
2.66M
2.08%
2.78M
4.24%
2.90M
4.33%
3.65M
25.88%
4.80M
31.61%
5.45M
13.46%
5.92M
8.78%
8.11M
36.89%
weighted average shs out dil
2.03M
-
2.42M
19.37%
2.61M
7.77%
2.66M
2.08%
2.78M
4.24%
2.90M
4.33%
3.65M
25.88%
4.80M
31.61%
5.45M
13.46%
5.92M
8.78%
8.11M
36.89%
eps
-18.32
-
-8.42
54.04%
-18.56
120.43%
-20.68
11.42%
-23.24
12.38%
-29.04
24.96%
-14.20
51.10%
-21.45
51.06%
-30.26
41.07%
-36.10
19.30%
-7.48
79.28%
epsdiluted
-18.32
-
-8.42
54.04%
-18.56
120.43%
-20.68
11.42%
-23.24
12.38%
-29.04
24.96%
-14.20
51.10%
-21.45
51.06%
-30.26
41.07%
-36.10
19.30%
-7.48
79.28%

All numbers in USD (except ratios and percentages)